Fig. 7.

Prophylactic studies against TC-1 tumor cells: Five groups of C57BL/6 mice were vaccinated with different regimens three times with a 2-week interval and then challenged with 1 × 10⁵ TC-1 in the right flank 2 weeks after second booster. Tumor volumes were measured twice a week (a). The percentage of tumor-free mice was determined over time in various groups (b)